Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2017 Apr 26;7:46741. doi: 10.1038/srep46741

A unifying mathematical framework for experimental TCR-pMHC kinetic constants

Jose Faro 1,2,a,*, Mario Castro 3,4,b,*, Carmen Molina-París 4
PMCID: PMC5405415  PMID: 28443634

Abstract

Receptor binding and triggering are central in Immunology as T cells activated through their T cell receptors (TCR) by protein antigens orchestrate immune responses. In order to understand receptor-ligand interactions, many groups working with different experimental techniques and assays have generated a vast body of knowledge during the last decades. However, in recent years a type of assays, referred to as two-dimensional or membrane-to-membrane, has questioned our current understanding of the role of different kinetic constants (for instance, on- versus off-rate constants) on TCR-ligand interaction and subsequent T cell activation. Here we present a general mathematical framework that provides a unifying umbrella to relate fundamental and effective (or experimentally determined) kinetic constants, as well as describe and compare state-of-the-art experimental methods. Our framework is able to predict the correlations between functional output, such as 1/EC50, and effective kinetic constants for a range of different experimental assays (in two and three dimensions). Furthermore, our approach can be applied beyond Immunology, and serve as a “translation method” for the biochemical characterization of receptor-ligand interactions.


T lymphocytes and their activation through T cell receptors (TCR) are essential components of most antigen-specific immune responses and their regulation. The cellular outcome of the interaction between a TCR and its ligand (a peptide bound to a major histocompatibility complex molecule [pMHC]) depends on their binding strength. However, how to quantitatively define this strength has proven a difficult task.

Technical developments in the last twenty years have notably increased our quantitative knowledge of the kinetics of pMHC recognition by T lymphocytes. Traditional assays for assessing TCR-pMHC interaction strength in terms of rate or affinity constants are designed such that TCRs or pMHC ligands are placed in solution (three-dimensional [3D] assays)1,2,3,4,5,6. However, classification of T cell ligands according to their 3D strength of interaction with TCRs was often inconsistent with their potency (level of functional output on T cells)1,7,8,9. To account for these discrepancies, it has been suggested that although 2D off-rates in the membrane environment could be estimated from solution measurements using a confinement time model7, ultimately direct measurements of in situ TCR-pMHC interaction kinetics would be required.

Two papers published in 201010,11 revealed essential differences between traditional assays and those in which TCRs and their pMHC ligands are confined to a membrane (referred to as 2D assays). These studies have, thus, dramatically highlighted the impact of dimensionality on the kinetics of reversible protein-protein interactions. For instance, adhesion frequency and thermal fluctuations assays10 showed not only significantly different estimations of kinetic parameters, such as the affinity constant or the off-rate constant but, perhaps more importantly, qualitative discrepancies in the classification of ligands according to their potency. This is summarized in Fig. 1, where we provide a comprehensive comparison of kinetic constants in 2D and 3D. This figure generalises that of ref. 12, as it provides a comprehensive account of the correlation between kinetic constants and the functional output of T cells (as measured by the inverse of the effective pMHC concentration stimulating half-maximal T cell proliferation, 1/EC50).

Figure 1. Correlation between T cell proliferation (potency), quantified through the value of 1/EC50, and TCR-pMHC effective kinetic parameters in 3D and 2D.

Figure 1

(a–c) pMHC functional potency versus TCR-pMHC 3D kinetics estimated with the surface plasmon resonance assay. (d–f) pMHC functional potency versus TCR-pMHC 2D kinetics estimated with the adhesion frequency assay. The data for the top row was adapted from refs 8,10, and data for the bottom row is based on ref. 10. Symbols correspond to the following ovalbumin-derived peptides (altered peptide ligands or APLs): ★, OVA; ⚪, A2; ×, G4; Inline graphic, E1; Inline graphic, V-OVA; Inline graphic, R4.

Figure 1 shows that the correlation between 1/EC50 (functional output) and kinetic constants is the opposite in 2D to that of 3D (based on refs 8,10). Similar conclusions were made by other authors using single-molecule fluorescence resonance energy transfer (FRET) microscopy at the cell level11. Thus, 2D on-rate constants appear to be, ultimately, responsible for the differences in ligand potency, suggesting that 2D experiments are mandatory in order to understand TCR-mediated T cell activation. This contradicts the (3D) previously held view that the off-rate constant was the main discriminant between ligands, given a fixed TCR, to assess their potency.

It is then timely to ask whether or not it is possible to reconcile 2D and 3D experimental observations, and thus, the large body of knowledge accumulated during the last decades on effective kinetic parameters of TCR-pMHC interactions. Furthermore, cellular decisions (proliferation, differentiation, migration, or death) are regulated by reversible protein-protein interactions, either in 2D or 3D scenarios. Thus, an answer to the previous question has important practical implications in Cell Biology.

In this paper, we approach this problem as follows. First, we develop a general mathematical framework, based on ordinary differential equations, to describe the different intermediate processes and chemical species involved in the specific binding of a TCR to its ligand in terms of fundamental constants for translational and rotational diffusion, as well as chemical binding. Then, based on a comprehensive analysis of current experimental assays, we identify which processes (translational diffusion, rotational diffusion or chemical binding) or species cannot be observed in each assay. In this way, we are able to relate fundamental and effective (or experimentally determined) kinetic constants. Thus, our mathematical approach makes explicit the meaning of effective kinetic constants, as used in the different experimental settings.

In summary, the proposed framework not only allows us to help understand current experimental differences in the estimation of TCR-pMHC kinetic parameters but, also, provides a unifying umbrella to describe and compare 2D and 3D state-of-the-art experimental systems for different ligand-receptor systems.

Results

Qualitative description of binding dynamics

Binding dynamics in 2D and 3D involve multiple steps, which can be purely chemical in nature or constrained by the geometry of the experiment. We can recognize three steps13,14,15,16,17, as depicted in Fig. 2: 1) diffusion/encounter, which is dimension dependent and ligand independent, 2) rotation/orientation, which is also dimension dependent (as the geometry constrains rotational degrees of freedom) and ligand independent, and 3) molecular association and dissociation, which only depends on the specific chemical properties of the interacting TCR and pMHC molecules. Only the binding step, or molecular complex formation, can potentially lead to an allosteric conformational change in the TCR, a possibility recently shown to occur in the TCR β chain9,18,19,20.

Figure 2. Three steps of binding in three versus two dimensions.

Figure 2

Top row, binding in three dimensions: (A) 3D diffusion/encounter, (B) rotation/orientation, and (C) molecular binding. Bottom row, the three binding steps in two dimensions: (D) 2D (membrane) diffusion/encounter, (E) rotation/orientation, and (F) molecular binding. The vertical line separates dimensional dependent and independent processes. The fundamental kinetic constants corresponding to each step in 3D and 2D have been included: Inline graphic, Inline graphic for diffusion/encounter, e+, e for rotation/orientation and k+, k for binding and unbinding, respectively. The fundamental kinetic constants are defined in Table 1.

General reaction kinetics and commonly used, specific ligand-receptor models

The qualitative picture (see Fig. 2) of the different binding steps in two and three dimensions can be expressed in terms of molecular kinetic reactions. Specifically,

graphic file with name srep46741-m147.jpg

where R is the concentration of free receptors (TCR), L the concentration of free ligands (pMHC), RL* a virtual (encounter) complex of one R and one L molecule characterized by being within the reaction distance, RL, a complex state similar to RL* but with R and L suitably oriented, i.e., potentially allowing the binding of TCR to pMHC, and finally, C the concentration of the bound complex (that would, eventually, trigger in T cells a signaling cascade). The fundamental (on and off) kinetic constants introduced in Fig. 2 and the reactions (1), as well as the corresponding affinity constants, are summarized in Table 1. In particular, k+ and k are, respectively, the chemical association and dissociation rate constants corresponding to a protein-protein complex (docked conformation) or reversible bond formation or disruption. They are denoted here the fundamental binding rate constants. When we compare experiments with different dimensionality, the explicit notation 2D or 3D will be used.

Table 1. Summary of the fundamental kinetic constants introduced in Eq. 1 and Fig. 2.

Step Dimension Parameter Units Description Refs
Diffusion 3D Inline graphic M−1 s−1 On-rate constant 16
Diffusion 3D Inline graphic s−1 Off-rate constant 16
Diffusion 3D Inline graphic M−1 Affinity 16
Rotation 3D Inline graphic s−1 On-rate constant 15,21
Rotation 3D Inline graphic s−1 Off-rate constant 15,21
Rotation 3D Inline graphic Affinity 15,21
Diffusion 2D Inline graphic Inline graphic s−1 On-rate constant 16
Diffusion 2D Inline graphic s−1 Off-rate constant 16
Diffusion 2D Inline graphic Inline graphic Affinity 16
Rotation 2D Inline graphic s−1 On-rate constant 15,21
Rotation 2D Inline graphic s−1 Off-rate constant 15,21
Rotation 2D Inline graphic Affinity 15,21
Binding k+ s−1 On-rate constant 15,21
Binding k s−1 Off-rate constant 15,21
Binding KA = k+/k Affinity 15,21

Note that the fundamental binding constants (k+, k) and the corresponding binding affinity constant (KA) are independent of the dimensionality of the experiment.

NA, Avogradro constant. Ac, effective cell surface area, defined as Ac = πa2, where a ≡ TCR encounter radius.

In order to compare different experimental assays, we only need to be concerned with observables that can be quantified over long enough times or in equilibrium, and thus, we ignore stochastic effects22. Consequently, the mathematical model that describes the above reactions (1) can be formulated, in a deterministic approximation, as the following system of coupled ordinary differential equations (ODEs):

graphic file with name srep46741-m1.jpg
graphic file with name srep46741-m2.jpg
graphic file with name srep46741-m3.jpg
graphic file with name srep46741-m4.jpg

where the square brackets represent the concentration of the different molecular species.

In the Supplementary Information (SI) we discuss the main 3D and 2D experimental assays used to analyze the kinetic constants of TCR-pMHC interactions, and describe what can be measured in each assay and the chemical model used to derive the different kinetic constants. This will allow us to select the reactions and/or chemical species described by equations (2), (3), (4), (5), that are grouped in each experimental assay. We identify four different “effective” models. These models are described in the following and in Fig. 3, where the relation between each “effective” model and the general one has been explicitly shown.

Figure 3. Summary of effective models. Species with angular brackets (〈.〉) denote effective meta-states.

Figure 3

These meta-states account for the lack of microscopic details in the given experimental assay. For each model, the first row shows the full model with green boxes that emphasize the implicit grouping behind a given experimental assay, and the second row describes the corresponding simplified or effective model.

Pre-binding model A (PBA)

In this model it is assumed that encounter and orientation take place in a single step, prior to molecular binding. The model groups the encounter and oriented complexes in a single chemical species that we denote by 〈RL〉. The rotation step is often neglected but, as shown by DeLisi15,23, it adds complexity to the frequently assumed pure diffusional mechanisms14,16. This model may correspond to the thermal fluctuation assay10.

Pre-binding model B (PBB)

In this model unbinding and disruption of orientation are assumed to take place in a single step, before the molecules diffuse away. This may also correspond to the thermal fluctuation assay10. This model includes FRET performed in solution (bulk FRET)6 and single molecule fluorescence microscopy (SMFM)24,25.

FRET model

The experimental system of ref. 11 allows to detect the encounter of the ligand and the receptor, but it cannot separately distinguish the initial species. Thus, if only the donor fluorescence signal is detected, this can be due to a free ligand or an encounter, non-oriented complex. On the other hand, FRET signals cannot discriminate between a bound TCR-pMHC complex and an oriented one (see Fig. 2). Mathematically, this means that we need to define meta-states composed of the original ones. Specifically, Inline graphic, Inline graphic and Inline graphic. These definitions are not mathematical artefacts but, rather, represent the inherent experimental uncertainty of FRET experiments.

Single-step model (SS)

In this case, the experimental assay can only distinguish between two states, bound and unbound, and therefore cannot discriminate between translational and rotational steps. As discussed in SI, this model applies to the adhesion frequency assay and the SPR assay.

The simplifications considered in the above models involve, ultimately, the introduction of effective kinetic constants, corresponding to the different steps in each effective model, and summarised in Fig. 3 and Table 2. In order to study these kinetic constants, we first formulate each effective model as a set of coupled ODEs, as has been done for the general model. We then express the assumptions of each effective model in mathematical terms and apply them to the general model. Finally, the effective kinetic constants are expressed in terms of the fundamental ones (for details, see SI). Note that, as summarized in Table 2, different effective kinetic constants have different meanings and values depending on the experimental assay under consideration.

Table 2. Summary of the effective kinetic constants for the effective models described in Fig. 3 and their relationship to the fundamental kinetic constants of Table 1.
Model effective constant Eq. no. Units Dimension Assay and references
PBA Inline graphic (6) s−1 2D TF ref. 10
koff = k (7) s−1 2D TF ref. 10
Inline graphic (8) 2D TF ref. 10
PBB Inline graphic (9) s−1 2D TF§ ref. 10
Inline graphic (10) s−1 2D TF§ ref. 10 and MD-SMFM ref. 25
Inline graphic (11) 2D TF§ ref. 10
Inline graphic (12) s−1 3D Bulk FRET ref. 6
Inline graphic (13) s−1 3D Bulk FRET ref. 6 and MD-SMFM ref. 24
Inline graphic (14) 3D Bulk FRET ref. 6
FRET Inline graphic (15) Inline graphics−1 2D SM-FRET ref. 11
Inline graphic (16) s−1 2D SM-FRET ref. 11
Inline graphic (17) Inline graphic 2D SM-FRET ref. 11
SS Inline graphic (18) Inline graphics−1 2D AF ref. 10
Inline graphic (19) s−1 2D AF ref. 10
Inline graphic (20) Inline graphic 2D AF ref. 10
Inline graphic (21) M−1s−1 3D SPR refs 2,6,7
Inline graphic (22) s−1 3D SPR refs 2,6,7
Inline graphic (23) M−1 3D SPR refs 2,6,7

PBA: Pre-binding model A; PBB: Pre-binding model B; FRET: FRET model; and SS: Single-step model.

TF, thermal fluctuation. MD-SMFM, molecular diffusion and single molecule fluorescent microscopy. FRET, fluorescence resonance energy transfer. SM, single molecule. AF, adhesion frequency. SPR, surface plasmon resonance.

Assuming unbinding implies a change of orientation.

§Assuming multiple binding/unbinding events take place before a change of orientation.

We note that while the PBA and the SS models have been widely used in the literature, as we show below, they cannot fully account for all the experimental observations reported in the literature of TCR-pMHC binding kinetics. We also note that the difference between the FRET and the SS models, is that the former groups together the following chemical species: R and RL* into 〈R〉, L and RL* into 〈L〉, and RL and C into 〈C〉, while the latter groups the three forward (reverse) reaction constants into a single effective forward (reverse) one, without the need to introduce the chemical species RL* and RL.

Understanding effective constant constants derived from 2D and 3D experimental assays

The preceding section provides a “translation tool” to help identify the effective constants for each effective model in terms of the fundamental ones, as shown in Table 2, Eqs (6)–(23). This “translation” allows to classify and compare experimental observations in the literature with a unified and general mathematical framework. We now illustrate our method by considering five different cases that cover the main experimental techniques currently used. We do so by carrying out pairwise comparisons of the estimations derived from 2D and 3D experimental assays.

Case 1: Adhesion frequency (AF) assay versus thermal fluctuation (TF) assay

This case corresponds to the two different experimental assays used by Zhu and colleagues10 to evaluate 2D kinetics. As indicated in Table 2, there are two possible interpretations of the effective off-rate constant measured by the TF assay in ref. 10. This depends on which of the two models, PBA or PBB, applies to this method. Taking into account the observation by Zhu and colleagues that the off-rate constants of the bound complex C (or meta-state 〈C〉) estimated by the AF and the TF assays are very similar10, we consider both the PBA and the PBB models. In the first case, the underlying assumption is that unbinding is accompanied by an instantaneous change in ligand orientation. In the second case, we allow for multiple binding/unbinding events before the ligand changes the optimal orientation.

Let us explore the implications of both assumptions:

  • Pre-binding Model A. In this model, the empirical observation that the AF and TF assays provide the same estimation of k, implies that Eqs (7) and (19) should provide the same result. Hence, the following equality must hold:
    graphic file with name srep46741-m8.jpg
    This implies that Inline graphic and, therefore,
    graphic file with name srep46741-m10.jpg
    That is, the binding on-rate constant is much slower than the rotational diffusion off-rate constant.
  • Pre-binding Model B. Likewise, the above constraint in this case implies the following equality, from Eqs (10) and (19):

graphic file with name srep46741-m11.jpg

Since Inline graphic, this, in turn, implies e < k. That is, the rotational diffusion off-rate constant is slower than the binding off-rate constant k+. However, the constraint Inline graphic cannot hold unconditionally, as the rate constant Inline graphic is ligand independent and k+, k are ligand dependent. Furthermore, the binding on- and off-rate constants change with ligand potency (for instance, compare ligands G4 and OVA in Fig. 1d,e), respectively. All this makes the PBB model unsuitable for describing TF assays.

We conclude that the TF assay is appropriately described by the PBA model, in which case, and as shown above:

graphic file with name srep46741-m15.jpg

The expression on the left implies that both the TF and the AF assays are suitable experimental tools to extract the fundamental binding off-rate constant k.

Once the correct model describing the TF assay has been identified, we observe that Inline graphic (see Eq. 10 in SI). That is, the effective on-rate constant k0n is directly proportional to the fundamental binding on-rate constant k+, with a ligand-independent proportionality factor E2D/(1+E2D). However, as computed in ref. 14, E2D ≈ 0.04 Inline graphic 1, therefore, Inline graphic (Eq. 6 in Table 2).

Case 2: AF assay versus surface plasmon resonance (SPR) assay

Case 1 showed how the analysis of the experimental data in the light of our mathematical description (PBA model for the TF assay, and 2D SS model for the AF assay), provides a consistent picture of the underlying fundamental processes, namely, transport, orientation and binding. In a similar vein, in this and the following subsections we analyze and compare the effective kinetic parameters obtained with different techniques involving the same or different dimensionality when making use of effective models.

This second case corresponds to the approach followed by Zhu and colleagues in ref. 10 to compare 2D and 3D kinetic parameters obtained, respectively, by the AF assay and the SPR assay1,26,27,28.

Since the kinetic molecular processes in these two experimental assays can be described by the same model, namely, the SS model, the effective on- and off-rate constants determined with both assays can be written in terms of identical equations (see Table 2). Furthermore, in both assays the effective on-rate constants range from Inline graphic to Inline graphic, and the effective off-rate constants from k to Inline graphic.

However, these two assays differ in both the diffusion and orientation rate constants. In 2D assays the diffusion on-rate constant (units of Inline graphics−1 ≡ μm2 mol−1 s−1) is given by Inline graphic, where D is the 2D diffusion coefficient, NA Avogadro’s number, b the mean distance between TCR molecules on the cell membrane, and Inline graphic the encounter radius (of the order of the diameter of a TCR)16. In contrast, in the SPR assay, we have Inline graphic, where v is the flow rate, h the height of the flow cell, and L the distance from the flow cell inset to the sampling area29. Therefore, the effective affinity constants obtained by the AF assay and the SPR assay, respectively, Inline graphic and Inline graphic, are different (in general) and, hence, their ratio is not one. Finally, as diffusion rate constants can be calculated from first principles, we can make use of experimental data to compute the ratio of the rotational diffusion affinity constants in 2D and 3D.

As shown above in Case 1, in the AF assay Inline graphic, hence it follows:

graphic file with name srep46741-m29.jpg

In contrast, in SPR experiments the effective 3D on-rate constant is almost independent of the ligand potency (see Fig. 1a) and, hence, it is independent of the binding constants. This experimental observation applied to the 3D SS model (Table 2) implies that Inline graphic, and hence:

graphic file with name srep46741-m31.jpg

This relation implies, in turn, that Inline graphic and Inline graphic.

In summary, our analysis of Cases 1 and 2, based on the experiments reported by Zhu and colleagues10, leads to:

graphic file with name srep46741-m34.jpg

which allows to deduce how the different effective 2D and 3D parameters in the SS model, corresponding to the AF and SPR assays, can be expressed in terms of the fundamental kinetic constants.

The log-log plots of ligand potency (measured as 1/EC50 for T cell proliferation) and 3D and 2D experimental rate constants as determined, respectively, with the SPR and AF assays (Fig. 1) can now be used to deduce the expected correlations between ligand potency and the fundamental kinetic and affinity constants, k+, k, and KA. To that end, we first calculate the log of each effective parameter. We obtain for the 2D SS model:

graphic file with name srep46741-m35.jpg

and for the 3D SS model:

graphic file with name srep46741-m36.jpg

Now, according to the experimental results in Fig. 1d–f, in the AF assay the value of the effective 2D on- and off-rate constants and the effective affinity constant, for all peptide ligands assayed, increases with ligand potency, respectively, about a thousand-fold range, a ten-fold range, and a thousand-fold range. From Eq. (24) it follows that the fundamental kinetic parameters k+, k, and KA span the same range as Inline graphic, Inline graphic, and Inline graphic, respectively. Moreover, the trend lines of the correlation between log(1/EC50) and the fundamental kinetic parameters have the same slopes as the respective ones of the effective parameters. Furthermore, except for the trend line of k, the trend lines of k+ and KA are shifted along the x-axis, relative to the trend lines of Inline graphic and Inline graphic, by a factor Inline graphic. To illustrate these results, in Fig. 4 we replot Fig. 1d–f and superimpose on each panel, the trend lines corresponding to the experimentally derived parameters in the AF assay, Inline graphic, Inline graphic, koff and Inline graphic (blue lines). Also superimposed are the estimated trend lines corresponding to the fundamental kinetic constants k+, k, KA (red lines).

Figure 4. Observed and expected trend lines between T cell functional output and effective (AF assay-derived) and fundamental kinetic constants for the set of peptides used in Fig. 1.

Figure 4

The blue solid lines correspond to the effective kinetic constants, Inline graphic, Inline graphic, Inline graphic and Inline graphic, as determined with the AF assay and the SS model. The red lines correspond to the fundamental binding constants (k+, k and KA). A dashed red line indicates an uncertainty in the direction and magnitude of the shift corresponding to a given fundamental binding parameter, depending on whether Inline graphic is positive or negative and whether Inline graphic is relatively large or small. See details in Cases 1, 2 and 4.

Strikingly, in respect to the results with the SPR assay, Eq. 25 indicates, on the one hand, that the effective on-rate constant Inline graphic is ligand independent, and on the other hand, that the effective off-rate constant Inline graphic is approximately the inverse of the effective affinity constant Inline graphic (proportional to the intrinsic binding affinity, KA). Not surprisingly, therefore, Fig. 1b,c shows that log(1/EC50) is negatively correlated to Inline graphic but positively correlated to Inline graphic.

Case 3: 2D fluorescent resonance energy transfer (FRET) assay versus SPR (3D) assay

This case corresponds to the approach followed by Davis and colleagues in ref. 11 in which the authors use 2D FRET and SPR assays to compare 2D and 3D kinetic parameters.

We have seen in Case 2 that for SPR experiments the effective on-rate constant is virtually ligand independent, and therefore Inline graphic and Inline graphic. This implies that the effective off-rate constant can be approximated by Inline graphic.

In the 2D FRET assay the effective on-rate constant is given by Inline graphic (see Table 2) and, hence, is ligand independent. On the other hand, the effective off-rate constant, Inline graphic, may or may not be ligand dependent, depending on whether KA is greater or lower than one. The relationship between this effective parameter and the expected ligand potency is therefore determined by the relative weights of k+ and k. Thus, if k+Inline graphick, the effective off-rate constant will be ligand independent. Since this is not what is experimentally observed, it follows that at most Inline graphic. This result implies that Inline graphic.

In summary, for both 2D FRET and SPR assays the effective on-rate constants are predicted to be ligand independent (for the most part). In contrast, in both assays the effective off-rate constants are inversely proportional to the intrinsic binding affinity, KA, but with different proportionality factors. These dependences indicate that, experiments like those reported in Fig. 1a–c, and similar ones using the 2D FRET assay, would be misleading if wrongly interpreted as providing an approximate estimation of the fundamental binding on- and off-rate constants.

Case 4: 2D FRET assay versus AF Assay

The two laboratories pioneering these two techniques claimed that they estimate the same kinetic parameters. However, they obtained different results (see refs 10,11). As shown below, comparison between both types of 2D experiments helps to understand the origin of these discrepancies.

The determined effective on-rate constants of 2D FRET and AF assays, discussed in Cases 1 and 3, are given by Eqs (15) and (18), respectively, Inline graphic and Inline graphic. That is, Inline graphic estimated in the 2D FRET assay is ligand-independent. In contrast, Inline graphic estimated in the AF assay is proportional to the fundamental binding on-rate constant, k+, with virtually the same proportionality factor for different ligands.

In the case of the effective off-rate constants of 2D FRET and AF assays, Inline graphic and Inline graphic (see Table 2), both effective parameters depend on the ligand. However, there is an important difference between both assays. While in the AF assay Inline graphic is approximately equal to the intrinsic binding off-rate constant, in the 2D FRET assay Inline graphic is inversely proportional to the intrinsic binding affinity constant KA. Therefore, it is quite possible that ligands with similar intrinsic binding off-rate constants show different effective binding off-rate constants in AF and 2D FRET assays.

In addition, the effective affinity constants also differ between both assays, with the former being given by E2D(KA + 1) and the latter by E2DKA. Thus, they will differ considerably for KAInline graphic 1, with the former being virtually E2D for pMHC ligands having different intrinsic binding affinity constants, and the latter being directly proportional to KA.

All this is summarized schematically in Fig. 5, where Fig. 1d–f is re-plotted with trend lines superimposed, which correspond to the effective kinetic parameters obtained with the 2D FRET and AF assays. We illustrate how 2D FRET is unable to capture the fundamental kinetic constants, k+ and k.

Figure 5. Observed and expected trend lines between T cell functional output and effective kinetic constants, derived from the 2D FRET and AF assays, for the set of peptides used in Fig. 1.

Figure 5

The dark blue lines correspond to the effective kinetic constants Inline graphic, Inline graphic, and Inline graphic from the AF assay. The cyan lines are the predicted trend lines for the correlation between log(1/EC50) and the logarithm of the effective parameters Inline graphic, Inline graphic, and Inline graphic from the 2D FRET assay, as inferred using the results in Cases 1 and 3 and further discussed in Case 4. Dashed vertical lines are drawn to help visualize the asymptotic limits of Inline graphic and Inline graphic. Their particular positions, as well as that of cyan lines, are for illustrative purposes.

Case 5: 2D FRET versus 3D FRET

Finally, we compare the 2D and 3D FRET assays. According to the results summarized in Eqs (9) and (15) in Table 2, the effective binding on-rates in 2D FRET and 3D FRET (or bulk FRET) assays are Inline graphic and Inline graphic, respectively. In contrast, their effective off-rates are formally similar, differing only in their corresponding dimensionality, namely, Inline graphic and Inline graphic. This implies that the effective on- and off-rates, and the corresponding affinity constants, differ in the 2D FRET and 3D FRET assays by the proportionality factors, Inline graphic, Inline graphic, and Inline graphic, respectively. It also implies that the trend lines of the expected correlation between ligand potency and 3D FRET kinetic parameters are essentially the same than for 2D FRET kinetic parameters (see Fig. 5).

All this is summarized schematically in Fig. 6, where Fig. 1a–c is re-plotted with trend lines superimposed, which correspond to the effective kinetic parameters obtained with the 3D FRET and SPR assays. We illustrate how 3D FRET has a vertical asymptote, and thus, is unable to capture the experimental features for lower values of the fundamental kinetic constants, k+ and k.

Figure 6. Observed and expected trend lines between T cell functional output and effective kinetic constants, derived from the 3D FRET and SPR assays, for the set of peptides used in Fig. 1.

Figure 6

The dark blue lines correspond to the effective kinetic constants Inline graphic, Inline graphic, and Inline graphic from the SPR assay. The cyan lines are the predicted trend lines for the correlation between log(1/EC50) and the logarithm of the effective parameters Inline graphic, Inline graphic, and Inline graphic from the 3D FRET assay, as inferred using the results in Case 5. Dashed vertical lines are drawn to help visualize the asymptotic limits of Inline graphic and Inline graphic. Their particular positions, as well as that of cyan lines, are for illustrative purposes.

We note that the comparison between the effective affinity constants of 2D FRET and AF assays, namely, Inline graphic and Inline graphic, could be used to estimate E2D, a rotational diffusion constant common to all pMHC ligands in cell membranes for peptide ligands with KAInline graphic 1.

Further, the comparison of the effective off-rate constants in 2D versus 3D FRET assays can be used to determine the 2D and 3D rotational diffusion constants as follows. First of all, we have already shown that Inline graphic (Eq. (9)). Secondly, we have Inline graphic14. Therefore, Inline graphic. This result and the fact that Inline graphic, yields Inline graphic. And, finally, from Inline graphic (see Eq. (15)) it follows Inline graphic.

Discussion

We have introduced and described a comprehensive mathematical framework, based on ordinary differential equations, that provides a unifying umbrella to describe and compare state-of-the-art experimental methods and also helps solve current experimental differences in the estimation of effective TCR-pMHC kinetic constants. Our study shows that much care must be taken when describing receptor-ligand interactions as a single step event, as this might not truly reflect the underlying complexity of these interactions, that involve both spatial processes (translational and rotational diffusion) and biochemical reactions.

Further, not only it reveals that what is called “on-” and “off-rate constants” often mean different things in different experimental assays, but also makes explicit their precise meaning in each assay. The same is true for a complex or a reaction product.

Moreover, in some cases the very concept of product cannot be defined due to limitations intrinsic to the experimental method. For example, in current FRET assays, being close enough and properly oriented cannot be distinguished from being bound. As we have shown here, the implications of this not only indicate that FRET experiments cannot yield estimations of on- and off-rate constants but help to properly interpret their results.

We believe our approach leads to two significant methodological improvements: on the one hand, making explicit the underlying hypothesis in a given experimental assay (and thus, in the experimentally determined kinetic constants), allows comparison with other assays and, on the other hand, theoretical models with finer granularity (more detailed steps) can help improve our understanding of how different molecular mechanisms contribute to receptor-ligand interactions, such as for example, mechanical versus chemical contributions30. Thus, splitting the binding step into two (or eventually, more) processes, such as actin recruiting and ligand-receptor binding, may help to decipher the role of mechanical forces in T cell activation.

Finally, we believe our analysis provides a clear route to identify the role of translational and rotational degrees of freedom in 2D and 3D experiments, and, for a fixed TCR, uniquely determines the relationship between the fundamental binding on- and off-rate constants and ligand potency.

Additional Information

How to cite this article: Faro, J. et al. A unifying mathematical framework for experimental TCR-pMHC kinetic constants. Sci. Rep. 7, 46741; doi: 10.1038/srep46741 (2017).

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Material

Supplementary Information
srep46741-s1.pdf (160.8KB, pdf)

Acknowledgments

This work has been partially supported by grants FIS2013-47949-C2-2-P and FIS2016-78883-C2-2-P (Spain), PIRSES-GA-2012-317893 (7th FP, EU), and BIOCAPS (FP7/REGPOT-2012- 2013.1, EC) under grant agreement no. 316265.

Footnotes

The authors declare no competing financial interests.

Author Contributions J.F. conceived the idea; J.F. and M.C. develop the mathematical models. All authors contributed to writing the paper and to scientific discussions.

References

  1. Stone J. D., Chervin A. S. & Kranz D. M. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology 126, 165–176, doi: 10.1111/j.1365-2567.2008.03015.x (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Rosette C. et al. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15, 59–70, doi: 10.1016/S1074-7613(01)00173-X (2001). [DOI] [PubMed] [Google Scholar]
  3. Holler P. D., Lim A. R., Cho B. K., Rund L. A. & Kranz D. M. CD8-T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. The Journal of experimental medicine 194, 1043–1052, doi: 10.1084/jem.194.8.1043 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Holler P. D., Chlewicki L. K. & Kranz D. M. TCRs with high affinity for foreign pMHC show self-reactivity. Nature immunology 4, 55–62, doi: 10.1038/ni863 (2003). [DOI] [PubMed] [Google Scholar]
  5. Gakamsky D. M., Luescher I. F. & Pecht I. T cell receptor-ligand interactions: a conformational preequilibrium or an induced fit. Proceedings of the National Academy of Sciences of the United States of America 101, 9063–9066, doi: 10.1073/pnas.0402840101 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gakamsky D. M. et al. Kinetic evidence for a ligand-binding-induced conformational transition in the T cell receptor. Proceedings of the National Academy of Sciences of the United States of America 104, 16639–16644, doi: 10.1073/pnas.0707061104 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Aleksic M. et al. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity 32, 163–174, doi: 10.1016/j.immuni.2009.11.013 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Edwards L. J., Zarnitsyna V. I., Hood J. D., Evavold B. D. & Zhu C. Insights into T cell recognition of antigen: significance of two-dimensional kinetic parameters. Frontiers in Immunology 3, doi: 10.3389/fimmu.2012.00086 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Depoil D. & Dustin M. L. Force and affinity in ligand discrimination by the TCR. Trends in immunology 35, 597–603, doi: 10.1016/j.it.2014.10.007 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Huang J. et al. The kinetics of two dimensional TCR and pMHC interactions determine T cell responsiveness. Nature 464, 932, doi: 10.1038/nature08944 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huppa J. et al. TCR–peptide–MHC interactions in situ show accelerated kinetics and increased affinity. Nature 463, 963–967, doi: 10.1038/nature08746 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Zarnitsyna V. & Zhu C. T cell triggering: insights from 2d kinetics analysis of molecular interactions. Physical biology 9, 045005, doi: 10.1088/1478-3975/9/4/04500 (2012). [DOI] [PubMed] [Google Scholar]
  13. Bell G. I. Models for the specific adhesion of cells to cells. Science 200, 618–627, doi: 10.1126/science.347575 (1978). [DOI] [PubMed] [Google Scholar]
  14. Dembo M., Goldstein B., Sobotka A. & Lichtenstein L. Histamine release due to bivalent penicilloyl haptens: the relation of activation and desensitization of basophils to dynamic aspects of ligand binding to cell surface antibody. The Journal of Immunology 122, 518–528, doi: www.jimmunol.org/content/122/2/511.short (1979). [PubMed] [Google Scholar]
  15. Delisi C. The effect of cell size and receptor density on ligand-receptor reaction rate constants. Molecular immunology 18, 507–511, doi: 10.1016/0161-5890(81)90128-0 (1981). [DOI] [PubMed] [Google Scholar]
  16. Lauffenburger D. & Linderman J. Receptors: models for binding, trafficking, and signaling (Oxford University Press, USA, 1996). [Google Scholar]
  17. Schreiber G. Kinetic studies of protein–protein interactions. Current Opinion in Structural Biology 12, 41–47, doi: 10.1016/s0959-440x(02)00287-7 (2002). [DOI] [PubMed] [Google Scholar]
  18. Liu B., Chen W., Evavold B. D. & Zhu C. Accumulation of dynamic catch bonds between TCR and agonist peptide-MHC triggers T cell signaling. Cell 157, 357–368, doi: 10.1016/j.cell.2014.02.053 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Das D. K. et al. Force-dependent transition in the T-cell receptor β-subunit allosterically regulates peptide discrimination and pMHC bond lifetime. Proceedings of the National Academy of Sciences of the United States of America 112, 1517–1522, doi: 10.1073/pnas.1424829112 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mallis R. J. et al. Pre-TCR ligand binding impacts thymocyte development before αβTCR expression. Proceedings of the National Academy ofSciences of the United States of America, doi: 10.1073/pnas.1504971112 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Dembo M. & Goldstein B. Theory of equilibrium binding of symmetric bivalent haptens to cell surface antibody: application to histamine release from basophils. The Journal of Immunology 121, 345–353, doi: http://www.jimmunol.org/content/121/1/345/tab-article-info (1978). [PubMed] [Google Scholar]
  22. Currie J., Castro M., Lythe G., Palmer E. & Molina-Pars C. A stochastic T cell response criterion. Journal of The Royal Society Interface 9, 2856–2870, doi: 10.1098/rsif.2012.0205 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. DeLisi C. & Wiegel F. W. Effect of nonspecific forces and finite receptor number on rate constants of ligand–cell bound-receptor interactions. Proceedings of the National Academy of Sciences 78, 5569–5572, doi: http://www.pnas.org/content/78/9/5569.short (1981). [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stepanek O. et al. Coreceptor scanning by the T cell receptor provides a mechanism for T cell tolerance. Cell 159, 333–345, doi: 10.1016/j.cell.2014.08.042 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O’Donoghue G. P., Pielak R. M., Smoligovets A. A., Lin J. J. & Groves J. T. Direct single molecule measurement of TCR triggering by agonist pMHC in living primary T cells. Elife 2, e00778, doi: 10.7554/eLife.00778 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Garcia K. C., Radu C. G., Ho J., Ober R. J. & Ward E. S. Kinetics and thermodynamics of T cell receptor- autoantigen interactions in murine experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 98, 6818–6823, doi: 10.1073/pnas.111161198 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weber K. S., Donermeyer D. L., Allen P. M. & Kranz D. M. Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proceedings of the National Academy of Sciences of the United States of America 102, 19033–19038, doi: 10.1073/pnas.0507554102 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jones L. L., Colf L. A., Stone J. D., Garcia K. C. & Kranz D. M. Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation. Journal of immunology (Baltimore, Md.: 1950) 181, 6255–6264, doi: 10.4049/jimmunol.181.9.6255 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sheehan D. Physical Biochemistry: Principles and Applications, 2 edn (Wiley, 2009). [Google Scholar]
  30. Kim S. T. et al. TCR Mechanobiology: Torques and Tunable Structures Linked to Early T Cell Signaling. Frontiers in immunology 3, 76, doi: 10.3389/fimmu.2012.00076 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information
srep46741-s1.pdf (160.8KB, pdf)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES